Alebund Pharmaceuticals (Jiangsu)
€1.6980
1
-€0.08-4.28%Tuesday 08:55
Statistics
Day High
1.856
Day Low
1.698
52W High
2.08
52W Low
1.594
Volume
-
Avg. Volume
-
Mkt Cap
577.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Aug 26Expected
Q2 2026
-0.07
0.26
0.59
0.93
Expected EPS
N/A
Actual EPS
-0.07194629376
Financials
-156.06%Profit Margin
Unprofitable13.46MRevenue
-21.01MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.
Show More
CEO
Dr. Guoyao Xia Ph.D.
Employees
169
Country
Hong Kong
ISIN
CNE100007QD0
WKN
000A42FHM
Listings
0 Comments
Share your thoughts
FAQs
What is Alebund Pharmaceuticals (Jiangsu) stock price today?▼
The current price of GX9.F is €1.70 EUR — it has decreased by -4.28% in the past 24 hours. Watch Alebund Pharmaceuticals (Jiangsu) stock price performance more closely on the chart.
What is Alebund Pharmaceuticals (Jiangsu) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Alebund Pharmaceuticals (Jiangsu) stocks are traded under the ticker GX9.F.
What is Alebund Pharmaceuticals (Jiangsu) market cap?▼
Today Alebund Pharmaceuticals (Jiangsu) has the market capitalization of 577.07M
When is the next Alebund Pharmaceuticals (Jiangsu) earnings date?▼
Alebund Pharmaceuticals (Jiangsu) is going to release the next earnings report on March 3, 2027.
What were Alebund Pharmaceuticals (Jiangsu) earnings last quarter?▼
GX9.F earnings for the last quarter are -0.07 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Alebund Pharmaceuticals (Jiangsu) revenue for the last year?▼
Alebund Pharmaceuticals (Jiangsu) revenue for the last year amounts to 13.46M EUR.
What is Alebund Pharmaceuticals (Jiangsu) net income for the last year?▼
GX9.F net income for the last year is -21.01M EUR.
How many employees does Alebund Pharmaceuticals (Jiangsu) have?▼
As of November 4, 2026, the company has 169 employees.
In which sector is Alebund Pharmaceuticals (Jiangsu) located?▼
Alebund Pharmaceuticals (Jiangsu) operates in the Other sector.
When did Alebund Pharmaceuticals (Jiangsu) complete a stock split?▼
Alebund Pharmaceuticals (Jiangsu) has not had any recent stock splits.
Where is Alebund Pharmaceuticals (Jiangsu) headquartered?▼
Alebund Pharmaceuticals (Jiangsu) is headquartered in Yangzhou, Hong Kong.